Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection
Fibrinolysis shutdown, as evidenced by elevated D-Dimer and complete failure of clot lysis at 30 minutes on thromboelastography, predicts thromboembolic events and need for hemodialysis in critically ill patients with COVID-19. Further clinical trials are required to ascertain the need for early therapeutic anticoagulation or fibrinolytic therapy to address this state of fibrinolysis shutdown.
Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients
This is 1 the first case series describing VV ECMO outcomes in COVID-19 patients. Our initial data suggest that VV ECMO can be successfully utilized in appropriately selected COVID-19 patients with advanced respiratory failure.
The COVID-19 Outbreak and its Impact on Hospitals in Italy: the Model of Cardiac Surgery
Whatever the strategy adopted, it is still unknown how this will impact the future needs of elective cardiac surgical procedures as well as of other procedures (e.g. neurosurgery) which cannot be performed with an inadequate availability of ICU beds.
COVID-19 Outbreak in France: Setup and Activities of a Mobile Extracorporeal Membrane Oxygenation Team During the First 3 Weeks
The setup of a mobile ECMO team within an experienced ECMO center is feasible and may help in the treatment of COVID-19 patients.
Hemodynamic Monitoring Options in COVID-19
We reflect on the clinical utility of select popular hemodynamic monitoring devices and suggest that the pulmonary artery catheter (PAC) shows empirical promise as a validated tool that maximizes monitoring capabilities and minimizes expenditure of hospital resources.
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
In our small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection. The universality and clinical implications of our observations require further research to define.
Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation
The purpose of this editorial is to briefly discuss COVID19-associated procoagulant and anticoagulant states in the context of ECMO support.
Assessing the Collateral Damage of the Novel Coronavirus: A Call to Action for the Post-COVID-19 Era
This paper explores the contemporary issues impacting healthcare resources during the pandemic and makes recommendations for identifying an appropriate balance of their use to optimize patient care.
Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare?
The objectives of this report are to describe the current status of post-acute cardiac care in Canada and to provide suggestions regarding the steps that policymakers and health care organizations can take to achieve preparedness in this area to reduce care fragmentation in the postCOVID-19 era.
Intraoperative Plasma Transfusion Volumes and Outcomes in Cardiac Surgery
In patients undergoing cardiac surgery who received intraoperative plasma transfusion, higher plasma transfusion volumes were associated with inferior clinical outcomes.
Turning Things Around: The Role of Prone Positioning in the Management of Acute Respiratory Failure After Cardiac Surgery
Prone positioning can be considered for the treatment of ARF after cardiac surgery to improve short-term respiratory conditions and possibly facilitate ECMO weaning.
Do Perioperative Protocols of Enhanced Recovery after Cardiac Surgery Improve Postoperative Outcome?
We conclude that FT or ERAS improve postoperative outcomes including length of stay and pain control, without increasing morbidity, mortality or readmission.